Gastrointestinal stromal tumor targeting drug Avapritinib (Avapriny, Ayvakit, BLU-285) is approved by USFDA on 9th January, 2020. The drug covers two indications: for the treatment of adult patients ...
The FoundationOne CDx (F1CDx) cancer biomarker detection method was approved by the FDA in November 2017 to detect 324 different genes that can identify viable mutations in 5 tumor types including ...
Gastrointestinal adverse reactions are one of the most common side effects including radiotherapy, chemotherapy, targeting and other treatments. Most of the gastrointestinal adverse reactions are naus...
Gastric adenocarcinoma is also a relatively common type of cancer, and its incidence is relatively high in China. There are many ways to treat gastric adenocarcinoma. The most common method is surgic...
Gastric cancer & chemotherapyChemotherapy is also one of the commonly used treatment methods for malignant tumors in the clinic. After chemotherapy, there may be adverse reactions of varying degre...
Food taken by the human body will enter the small intestine area through the throat, and then digest and absorb through the small intestine and the large intestine. If you eat food that is too spicy a...
Due to the long-term irregular diet or love to eat spicy and irritating food, many young people are faced with gastroenteritis. If left unattended, it will lead to cell cancer and the possibility of g...
Genetic testing for gastric cancerAfter nearly ten years of development, tumor genetic testing has become the immediate need of a large number of cancer patients. The test report guidance provided by...
Gastric cancer is growingGastric cancer remains one of the most common and deadly cancers worldwide, especially among older males. Based on GLOBOCAN 2018 data, stomach cancer is the 5th most common n...
Gastritis and gastric cancer Severe inflammation in certain tissues and organs of the body is usually related to the occurrence of cancer, but the mechanism of this situation is still unclear. In...